These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7403408)

  • 21. An adverse reaction to piracetam in an hypothyroid 10 year old boy.
    Waters B; Resnick M; Simeon J; Trites R; Fiedorowicz C
    Prog Neuropsychopharmacol; 1980; 4(2):207-9. PubMed ID: 7403353
    [No Abstract]   [Full Text] [Related]  

  • 22. Piracetam as an aid to learning in dyslexia. Preliminary report.
    Wilsher C; Atkins G; Manfield P
    Psychopharmacology (Berl); 1979 Sep; 65(1):107-9. PubMed ID: 116285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Piracetam in child neuropsychiatry. Clinical experimentation in a child neuropsychiatry department].
    Vampirelli P
    Minerva Pediatr; 1978 Feb; 30(4):373-6. PubMed ID: 147984
    [No Abstract]   [Full Text] [Related]  

  • 24. [Piracetam in the treatment of alcohol-induced delirium].
    Snel H; Lehmann E; Velikonja M
    MMW Munch Med Wochenschr; 1983 Oct; 125(42):947-9. PubMed ID: 6417503
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of Piracetam on dyslexic's reading ability.
    Wilsher C; Atkins G; Manfield P
    J Learn Disabil; 1985 Jan; 18(1):19-25. PubMed ID: 3881545
    [No Abstract]   [Full Text] [Related]  

  • 26. A double blind trial of piracetam (UCB 6215) and placebo in cases of post-ECT cognitive deficiency.
    Bagadia VN; Gada MT; Mundra VK; Simon S; Doshi JM; Pradhan PV; Shah LP; Sheth UK
    J Postgrad Med; 1980 Apr; 26(2):116-20. PubMed ID: 7012328
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of therapeutic response to long-term treatment with lecithin versus piracetam plus lecithin in patients with Alzheimer's disease.
    Smith RC; Vroulis G; Johnson R; Morgan R
    Psychopharmacol Bull; 1984; 20(3):542-5. PubMed ID: 6433396
    [No Abstract]   [Full Text] [Related]  

  • 28. [Piracetam as a corrector of long-term learning disorders caused by prenatal alcohol exposure: the significance of the length of therapy].
    Trofimov SS; Ostrovskaia RU; Smol'nikova NM; Kravchenko EV; Nemova EP; Voronina TA
    Biull Eksp Biol Med; 1996 Apr; 121(4):435-7. PubMed ID: 8829460
    [No Abstract]   [Full Text] [Related]  

  • 29. [Trial of piracetam in children with cerebral organic mental deficiency].
    Rösler HD; Kleinpeter U; Gehrke R; Hinz G; Krause G
    Psychiatr Neurol Med Psychol (Leipz); 1977 Jun; 29(6):350-9. PubMed ID: 335419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapeutic effects of Nootropyl].
    Houillon P; Kitenge A; Jouannigot R; Lullien L
    Ann Med Psychol (Paris); 1980; 138(7):869-76. PubMed ID: 7458110
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical trial of piracetam in disorders of consciousness due to head injury.
    Calliauw L; Marchau M
    Acta Anaesthesiol Belg; 1975 Apr; 26(1):51-60. PubMed ID: 773078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of piracetam upon visual event-related potentials in dyslexic children.
    Conners CK; Reader M; Reiss A; Caldwell J; Caldwell L; Adesman A; Mayer L; Berg M; Clymer R; Erwin R
    Psychophysiology; 1987 Sep; 24(5):513-21. PubMed ID: 3685231
    [No Abstract]   [Full Text] [Related]  

  • 33. [Legasthenia. Diagnosis, therapy--experiences in a child and adolescent psychiatric ambulatory].
    Mönikes HJ
    Fortschr Med; 1977 Feb; 95(8):505-9. PubMed ID: 852818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nootropyl (piracetam)--memory disorders].
    Holmboe AM
    Tidsskr Nor Laegeforen; 1977 Feb; 97(6):309-10. PubMed ID: 847681
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of enuresis: a study with imipramine, amitriptyline, chlordiazepoxide-clidinium and piracetam.
    Yurdakök M; Kinik E; Bedük Y; Güvenç H; Us O
    Turk J Pediatr; 1986; 28(3):171-5. PubMed ID: 3564164
    [No Abstract]   [Full Text] [Related]  

  • 36. [Piracetam treatment of pseudohallucinatory phenomena induced by ketamine].
    Saba G; Marchi A; Passino N; di Martino MR
    Minerva Anestesiol; 1983 Apr; 49(4):215-8. PubMed ID: 6866270
    [No Abstract]   [Full Text] [Related]  

  • 37. Piracetam in alcoholic psychoses: a double-blind, crossover, placebo controlled study.
    Skondia V; Kabes J
    J Int Med Res; 1985; 13(3):185-7. PubMed ID: 3891457
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effects of piracetam in healthy dogs and dogs with experimental neuroses].
    Aĭrapetiants MG; Mekhedova AIa
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1981; 31(6):1164-70. PubMed ID: 7199230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Piracetam: physiological disposition and mechanism of action.
    Tacconi MT; Wurtman RJ
    Adv Neurol; 1986; 43():675-85. PubMed ID: 3946121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of acoustic traumatism with injectable vincamine. Random double blind clinical trial with a complementary comparative element (author's transl)].
    Hennebert D; De Heyn G
    Rev Med Brux; 1982 Jan; 3(1):37-43. PubMed ID: 7038815
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.